Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.55
-0.88 (-11.84%)
Feb 12, 2026, 10:23 AM EST - Market open
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
$587,242
Profits / Employee
-$599,114
Market Cap
387.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | 292 | 8 | 2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 353 |
| Kyverna Therapeutics | 129 |
| Invivyd | 100 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| PureTech Health | 56 |
| Eupraxia Pharmaceuticals | 33 |
| Zura Bio | 30 |
VNDA News
- 18 hours ago - Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 7 days ago - Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - PRNewsWire
- 27 days ago - Vanda Pharmaceuticals Inc. (VNDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Vanda and Exante Data Combine in Strategic Merger - Business Wire
- 5 weeks ago - Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder - PRNewsWire
- 6 weeks ago - Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus - Seeking Alpha
- 6 weeks ago - Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval - Barrons
- 6 weeks ago - US FDA approves Vanda Pharmaceuticals' motion sickness drug - Reuters